Volume Spike Investor

ACADIA Pharmaceuticals (NASDAQ: ACAD) is already having a horrible day and is likely going to crisis-mode.  Shares are being more than cut in half and we have already past 150,000 shares even though it is only 8:20 AM EST.  Shares were halted after closing at $8.49 on Friday, but have re-opened down under $4.00 in early-bird trading.

The company’ phase IIb schizophrenia is a bust on all accounts.

52-week trading range was $7.63 to $17.33.
Average Volume:  220,000
OPTIONS:       YES

Jon Ogg
June 16, 2008